Compare Cardinal Health Inc (CAH) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs United Microelectronics Corp — how do they compare? Cardinal Health Inc trades at $235.98 (market cap $55.88B), while United Microelectronics Corp trades at $19.45 (market cap $47.81B). The key difference: Cardinal Health Inc is the larger of the two by market cap, and United Microelectronics Corp pays the higher dividend (2.12%). Which is the better fit depends on your goals.
| CAH | UMC | |
|---|---|---|
Market Cap | $55.88B | $47.81B |
Sector | Health | Technology |
52-Week High | $240.26 | $28.02 |
52-Week Low | $146.04 | $6.58 |
Enterprise Value | $59.91B | $44.93B |
Dividend Yield | 0.86% | 2.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $237.18, up 0.33% on the day, near its 52-week high. The stock shows bullish technical signals with consistent earnings beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%. Positive sentiment is driven by strong Q4 2026 results and optimistic fiscal 2027 guidance highlighted by Reuters on August 11, 2026.
Outlook remains favorable with analyst consensus price target of $266.43 implying 12% upside. Key opportunities include pharmaceutical segment strength and dividend payments, while risks involve high debt levels and thin profit margins. The bullish analyst stance (54.55% buy ratings) supports growth potential, but investors should monitor cash flow volatility and competitive pressures.
UMC trades at $18.79, up 0.37% today, with a bearish technical signal. Recent earnings beats and strong July 2026 sales growth of 18.98% year-over-year highlight operational momentum. The company is expanding capacity in Singapore and Taiwan to meet AI-driven demand, supported by a robust balance sheet with $115.24 billion in cash. However, net income margin has declined from 32.1% in 2022 to 16.99% in 2025, posing a concern.
The outlook is mixed; expansion initiatives and AI tailwinds offer growth potential, but margin compression and a bearish technical stance present risks. Analyst consensus is cautious with 53.33% hold ratings. Key catalysts include Q3 2026 earnings and fab expansion progress, while competitive pressures and macroeconomic volatility remain headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
